| NCT ID | NCT03361228 |
| Title | A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | no |
| Sponsors | Incyte Corporation |
| Indications | |
| Therapies | |
| Age Groups: | adult senior |